Skip to content

Merck & Company Inc Price, Chart & Factor Exposure

Free Data & Analytics Access
Merck & Company Inc · E.MRK.BE · Germany
Use symbol E.MRK.BE in our API & Excel add-in to retrieve this data ↓
109.20
(-0.02%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum -100%
Trend -75%
Bubble Risk LOW
Realised Volatility (20D) 40.18%

Merck & Company Inc Forecast

Merck & Company Inc short-term momentum is strongly negative (up over 0 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term SELL signal. The long-term trend is strongly negative (1 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term SELL signal. Based on 20-day realised volatility of 40.2% a year, a typical one-standard-deviation range is 103.01–115.38 over a week, 96.53–121.86 over a month and 65.32–153.07 over a year. (Signals as of 21 Nov 2026.)

Merck & Company Inc Price Chart

MacroFinance.ai

Merck & Company Inc Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Merck & Company Inc
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Merck & Company Inc
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Merck & Company Inc
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Merck & Company Inc
P/E
16.06x
Cheap vs own history
QoQ +0.6%
YoY 0.0%
now 16.060715.97 low18.08 high
ⓘP/E As of 22 Nov 2026.See Merck & Company Inc returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Merck & Company Inc
P/S
2.23x
Cheap vs own history
QoQ +0.6%
YoY 0.0%
now 2.23192.22 low2.51 high
ⓘP/S As of 22 Nov 2026.See Merck & Company Inc returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Merck & Company Inc
P/B
1.64x
Cheap vs own history
QoQ +0.6%
YoY 0.0%
now 1.64071.63 low1.85 high
ⓘP/B As of 22 Nov 2026.See Merck & Company Inc returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Merck & Company Inc
FCF Yield
4.1%
Strong vs own history
QoQ −0.6%
YoY 0.0%
now 4.07373.62 low4.1 high
ⓘFCF Yield As of 22 Nov 2026.See Merck & Company Inc returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Merck & Company Inc
Earnings Yield
6.2%
Strong vs own history
QoQ −0.6%
YoY 0.0%
now 6.22645.53 low6.26 high
ⓘEarnings Yield As of 22 Nov 2026.See Merck & Company Inc returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Merck & Company Inc
Market Cap
$47.5B
Lowest in 5 years
QoQ +0.6%
YoY 0.0%
now 47475.570447,206 low53,442 high
ⓘMarket Cap As of 22 Nov 2026.See Merck & Company Inc returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Merck & Company Inc
Current Ratio
1.49x
Strong vs own history
QoQ 0.0%
YoY 0.0%
ⓘCurrent Ratio As of 22 Nov 2026.See Merck & Company Inc returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Merck & Company Inc
Quick Ratio
0.97x
Strong vs own history
QoQ 0.0%
YoY 0.0%
ⓘQuick Ratio As of 22 Nov 2026.See Merck & Company Inc returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Merck & Company Inc
Interest Coverage
12.60x
Mid-range vs own history
QoQ 0.0%
YoY 0.0%
ⓘInterest Coverage As of 22 Nov 2026.See Merck & Company Inc returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Merck & Company Inc
Piotroski F-Score
8
Mid-range vs own history
QoQ 0.0%
YoY 0.0%
ⓘPiotroski F-Score As of 22 Nov 2026.See Merck & Company Inc returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Merck & Company Inc
Altman Z-Score
2.76
Weak vs own history
QoQ +0.3%
YoY 0.0%
now 2.76112.75 low2.92 high
ⓘAltman Z-Score As of 22 Nov 2026.See Merck & Company Inc returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  14 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, FCF Growth and moreSign up
Accounting Red Flags
  17 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Merck & Company Inc, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Merck & Company Inc fundamentals: income statement, balance sheet & cash flow

Merck & Company Inc reported revenue of €21.16bn and net income of €2.78bn in FY2024, the year ended 31 December 2024 — revenue up 0.8% and net income down 1.7% on the prior year. Free cash flow was €2.40bn. These figures are as reported in the filings, not restated: 9 fiscal years and 27 quarters of history, back to December 2016.

Revenue (FY2024)
€21.16bn
+0.8%
Net income
€2.78bn
-1.7%
Gross margin
59.01%
Free cash flow
€2.40bn
+36.4%
Net debt
€7.36bn
Merck & Company Inc income statement, annual, as reported · EUR billions unless stated
EUR billionsFY2024FY2023FY2022FY2021FY2020
Period end31 Dec 202431 Dec 202331 Dec 202231 Dec 202131 Dec 2020
Revenue21.1620.9922.2319.6917.53
Cost of revenue8.678.608.537.356.84
Gross profit12.4912.3913.7112.3410.70
Research & development2.282.452.522.432.29
Operating income4.023.574.754.212.81
EBITDA——6.555.964.96
Interest expense0.290.320.240.270.39
Pre-tax income3.543.484.293.922.63
Net income2.782.823.333.061.99

Download Merck & Company Inc fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.MRK.BE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks the full history, the filing vintages behind each number and API access.
Create free account

Figures in EUR, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.

Research on Merck & Company Inc

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Merck & Company Inc Trading Strategies

9 backtested tactical asset allocation strategies hold VGK (European market), the closest tradable exposure to Merck & Company Inc; 1 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

Explore all strategies →

Statistical Distribution of Returns

Plus

How Merck & Company Inc’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Merck & Company Inc behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Merck & Company Inc (Germany)

Merck & Company Inc is a listed security in Germany. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Merck & Company Inc

Frequently asked questions

What is Merck & Company Inc?
Merck & Company Inc is a listed security in Germany. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Merck & Company Inc price?
The latest close is 109.2 (21 Nov 2026), -0.02% on the day. The price at the top of the page refreshes during the trading day.
Is Merck & Company Inc in an uptrend?
As of 21 Nov 2026, short-term momentum is strongly negative (0 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly negative (1 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Merck & Company Inc?
20-day realised volatility is 40.2% a year (21 Nov 2026), which implies a typical one-standard-deviation move of about 11.6% over a month and 5.7% over a week.
What factors affect Merck & Company Inc?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Merck & Company Inc, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Merck & Company Inc?
9 backtested tactical asset allocation strategies trade Merck & Company Inc through VGK; 1 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Merck & Company Inc returns analysed?
The Statistical Distribution of Returns section shows the distribution of Merck & Company Inc daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Merck & Company Inc historical data?
In the Free historical data section of this page: the last 10 years of Merck & Company Inc daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Merck & Company Inc historical data (last 10 years)

Browse or instantly download the last 10 years of Merck & Company Inc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.MRK.BE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-03-18109.195
2026-03-17111.296
2026-03-16108.078
2026-03-13108.575
2026-03-12109.367
2026-03-11110.002
2026-03-10111.163
2026-03-09108.898
2026-03-06121.324
2026-03-05122.265
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

There is no Profile data available for MRK.BE.